A kidney cancer-related organoid combination and its application
A technology of organoids and kidney cancer, applied in cell culture and drug screening, and the field of kidney cancer organoid culture, can solve the problems of shortage, immature culture conditions of kidney cancer organoids, enhance the sensitivity and pertinence of clinical drugs, and achieve The effect of reducing tissue volume requirements
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] Culture process of a kidney cancer organoid combination
[0055] 1. Wash tumor biopsy tissue samples twice with PBS; clinical renal cancer patients with inferior vena cava thrombosis
[0056] 2. Removal of necrotic mucous tissue;
[0057] 3. The remainder was minced using sterile scissors in ADDF++ (advanced DMEM / F12 with 1×Glutamax, 10mM HEPES and antibiotics) solution containing 1 mg / mL collagenase (Sigma, C9407) and 10 μM Y-27632. Small pieces of about 5mm, incubate at 37°C for 1 hour, and aspirate the lysate every 15 minutes to facilitate digestion;
[0058] Note: ADDF+++ medium: Advanced DMEM / F12+1×Glutamax+10mM HEPES+antibiotics+1 mg / mL collagenase (Sigma, C9407)+10 μM Y-27632. (The antibiotic is a combination of penicillin + streptomycin, and the concentration is: the working concentration of penicillin is 100U / mL, and the working concentration of streptomycin is 0.1 mg / mL)
[0059] For all subsequent steps, the pipette tip needs to be pre-wetted with DMEM+1% ...
Embodiment 2
[0075] Using 10 patients with renal cancer, the success rate (9 / 10): 10 patients were unsuccessful in the culture of renal cancer tumor thrombus, and both renal cancer tissue and renal tissue organoids were successfully cultured;
[0076] Maintenance Difficulty: Culture in a 37°C, 5% CO2 incubator. As needed, the kidney organoid growth medium is renewed every 3-4 days, with a high success rate.
Embodiment 3
[0078] The specific screening drugs are as follows in Table 1
[0079] Table 1 shows the screened drugs and their data
[0080]
[0081]
[0082] Dose-response curve: The concentration of candidate drugs in the drug screening based on the organoid model in this study was determined by the relationship of the dose-response curve. Based on the drug concentration as the abscissa and the action intensity as the ordinate, the drug dose was judged, and the candidate evaluation drugs were all evaluated. Select the amount of drug within the therapeutically safe range for drug susceptibility testing.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com